Ultra-Marathon Running Depletes Athletes' Red Blood Cells, Study Finds
via HealthDayTHURSDAY, Feb. 19, 2026 — Ultra-marathon runners must be incredibly fit to endure races that can extend more than 100 miles, but their bodies pay a price for their athleticism, a new study says.
Extreme endurance runners experience a breakdown of their normal red blood cells during a race, putting them at increased risk of anemia, researchers reported Feb. 18 in the journal Blood: Red Cells & Iron.
Essentially, the damage done by such long-distance running causes accelerated aging and breakdown of red blood cells, and this destruction mounts as the miles stack up, researchers found.
“Based on these data, we don’t have guidance as to whether people should or should not participate in these types of events,” said lead researcher Travis Nemkov, an associate professor of biochemistry and molecular genetics at the University of Colorado Anschutz.
“What we can say is, when they do, that persistent stress is damaging the most abundant cell in the body,” Nemkov said in a news release.
For the study, researchers compared blood samples drawn before and after athletes participated in two French world-class running events: the 25-mile Martigny-Combes à Chamonix race and the 106-mile Ultra Trail de Mont Blanc race.
By comparison, a typical marathon is 26.2 miles long.
Samples were taken from 11 runners in the shorter race and 12 in the longer event.
The team specifically looked at changes in the runners’ red blood cells, which transport oxygen, nutrients and waste products throughout the body.
These cells must be flexible enough to squeeze through small blood vessels, but results showed that the cells become less flexible over the course of an endurance race.
Blood pressure changes, inflammation and oxidative stress all caused damage to red blood cells during long-distance running, researchers found.
This pattern of damage was clearly seen after the 25-mile race and was amplified in the 106-mile race, researchers found.
“At some point between marathon and ultra-marathon distances, the damage really starts to take hold,” Nemkov said.
As the length of a run increases, athletes can expect to lose more red blood cells and accumulate more damage to those cells remaining in circulation, researchers said.
However, researchers can’t say how this depletion of red blood cells will affect athletes’ short-term or long-term health.
“We’ve observed this damage happening, but we don’t know how long it takes for the body to repair that damage, if that damage has a long-term impact, and whether that impact is good or bad,” Nemkov said.
Further study could help not only endurance athletes but also everyday folks needing a blood transfusion, researchers noted.
Stored blood starts to break down after a few weeks of storage, and becomes unusable for transfusions after six weeks. Insights gained from endurance athletes might reveal better ways to handle and preserve blood donations, researchers said.
“Red blood cells are remarkably resilient, but they are also exquisitely sensitive to mechanical and oxidative stress,” said senior researcher Angelo D’Alessandro, a professor at the University of Colorado Anschutz.
“This study shows that extreme endurance exercise pushes red blood cells toward accelerated aging through mechanisms that mirror what we observe during blood storage,” D’Alesandro said in a news release. “Understanding these shared pathways gives us a unique opportunity to learn how to better protect blood cell function both in athletes and in transfusion medicine.”
Researchers plan to repeat this study using more participants and additional blood samples taken during and after races.
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2026-02-20 09:26
Read more
- Sandoz Receives US FDA Approval to Expand Enzeevu (aflibercept-abzv) Label for Multiple Retinal Indications
- Genentech’s Fenebrutinib Is the First Investigational Medicine in Over a Decade That Reduces Disability Progression in Primary Progressive Multiple Sclerosis (PPMS)
- Cumberland Pharmaceuticals Receives FDA Fast Track Designation for its Ifetroban Duchenne Muscular Dystrophy Program
- Firearm Injuries Tied to Long-Term Physical, Functional Health Challenges
- Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA PF’3944 Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial
- FDA Approves Filkri (filgrastim-laha), a Biosimilar to Neupogen
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions